VirusExpress® Lentivirus Production Platform
Source: MilliporeSigma
You’re developing lifesaving gene-modified cell therapies and need to manufacture lentiviral vector as quickly as possible. But scale-up and regulatory hurdles make the path to the clinic slow and labor intensive.
We're here to help.
The VirusExpress® Lentiviral Production Platform offers a transfection-based solution using a suspension cell line, chemically defined medium, and a process with proven performance at scale.
Draw on our 30+ years of viral vector manufacturing experience and a platform that can dramatically reduce your process development and scale-up time to speed your therapy to patients.
Find out how you can draw on our experience to get on the fast track through production.
MilliporeSigma
This website uses cookies to ensure you get the best experience on our website. Learn more